Acadia Healthcare Company, Inc. $ACHC Stock: Hohimer Wealth Management LLC Lowers Position

Hohimer Wealth Management LLC lessened its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 12.2% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 213,260 shares of the company’s stock after selling 29,590 shares during the period. Hohimer Wealth Management LLC’s holdings in Acadia Healthcare were worth $5,865,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in ACHC. BlackRock Inc. purchased a new position in Acadia Healthcare during the second quarter worth about $441,685,000. Jefferies Financial Group Inc. purchased a new stake in shares of Acadia Healthcare in the 2nd quarter valued at about $106,458,000. Deutsche Bank AG purchased a new stake in shares of Acadia Healthcare in the 2nd quarter valued at about $49,746,000. Bank of America Corp DE purchased a new stake in shares of Acadia Healthcare in the 2nd quarter valued at about $21,606,000. Finally, First Trust Advisors LP boosted its position in shares of Acadia Healthcare by 73.0% during the 1st quarter. First Trust Advisors LP now owns 1,689,442 shares of the company’s stock valued at $39,516,000 after acquiring an additional 712,852 shares during the last quarter.

Acadia Healthcare News Summary

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Acadia reported third-quarter EPS of $0.60, ahead of the $0.46 consensus, and revenue of $895.3 million, above estimates and up 5.1% year over year. The company also raised its full-year guidance, with its outlook described as slightly above expectations. Article
• Positive Sentiment: Guggenheim raised its target to $41 and kept a Buy rating; RBC lifted its target from $31 to $41 and maintained Outperform. These revisions reinforce optimism about further gains. Article Article
• Neutral Sentiment: Cantor Fitzgerald raised its target to $39 but retained a Neutral rating, signaling a more cautious view than the bullish analyst calls. Analyst rating
• Negative Sentiment: Quarterly EPS was below the $0.72 reported a year earlier. Barclays raised its target to $35 but kept an Equal Weight rating; that target is below the cited current share price, suggesting limited upside in its view. Analyst rating

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Wall Street Zen raised Acadia Healthcare from a “hold” rating to a “buy” rating in a report on Saturday. Raymond James Financial downgraded shares of Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $39.00 target price on the stock. in a research note on Monday, September 28th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, September 9th. TD Cowen lifted their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Finally, Cantor Fitzgerald boosted their price target on shares of Acadia Healthcare from $30.00 to $39.00 and gave the stock a “neutral” rating in a research note on Friday. Eight analysts have rated the stock with a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Hold” and an average price target of $32.54.

Acadia Healthcare Price Performance

ACHC opened at $37.00 on Monday. The business’s fifty day simple moving average is $29.40 and its 200 day simple moving average is $26.14. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $39.38. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.15. The stock has a market cap of $3.44 billion, a PE ratio of -2.97, a P/E/G ratio of 10.57 and a beta of 0.64.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, November 4th. The company reported $0.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.46 by $0.14. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.07%. The firm had revenue of $895.31 million during the quarter, compared to analyst estimates of $877.76 million. During the same quarter in the previous year, the company posted $0.72 earnings per share. The company’s revenue was up 5.1% compared to the same quarter last year. As a group, research analysts expect that Acadia Healthcare Company, Inc. will post 1.75 earnings per share for the current fiscal year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc is a U.S. provider of behavioral health services. The company operates facilities that treat mental health conditions and substance use disorders, serving patients through inpatient, residential and outpatient care.

Its services include psychiatric hospitals, specialty treatment centers, residential programs and outpatient clinics. Care may include assessment, therapy, medication management and treatment for addiction, depending on the facility and program.

Founded in 2005 and headquartered in Franklin, Tennessee, Acadia serves communities across the United States.